» » »

Cancer-Causing Proteins Durham NC

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

Douglas Rivera, MD
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Sascha A Tuchman
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Hematology

Data Provided by:
David Guy Kirsch
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Radiation Oncology

Data Provided by:
Cassandra Nicole Moore, MD
(919) 684-5199
DUME 3841,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Female
Education
Medical School: Univ Of Nm Sch Of Med, Albuquerque Nm 87131
Graduation Year: 1999

Data Provided by:
Jeffrey Crawford
(919) 620-4467
Duke University Medical Ctr
Durham, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
Brian Gary Czito, MD
(919) 668-7336
Box 3085,
Durham, NC
Specialties
Oncology (Cancer), Radiation Oncology
Gender
Male
Education
Medical School: Med Coll Of Ga Sch Of Med, Augusta Ga 30912
Graduation Year: 1996

Data Provided by:
James J Vredenburg, MR
(919) 684-5301
3624 DUMC,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Gary Herbert Lyman
(919) 684-8111
2100 Erwin Rd
Durham, NC
Specialty
Hematology / Oncology, Medical Oncology

Data Provided by:
John Chute
(919) 620-4467
Duke University Medical Ctr
Durham, NC
Specialty
Medical Oncology

Data Provided by:
Nelson Jen An Chao, MD
(919) 668-1010
DUMC Box 3961,
Durham, NC
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: Yale Univ Sch Of Med, New Haven Ct 06510
Graduation Year: 1981

Data Provided by:
Data Provided by:

Cancer-Causing Proteins

Provided By:

Scientists are closer to understanding how a recently approved class of antibiotics may work against cancer.

The drugs, called thiazole antibiotics, appear to block a cellular protein called FoxM1, one of the most over-produced proteins in cancer cells, according to researchers at the University of Illinois at Chicago College of Medicine. FoxM1 is believed to play an important role in causing cells to become cancerous and may present a promising target for future anti-cancer treatments.

The researchers also found that thiazoles may inhibit proteasomes, a molecular complex within cells that disposes of old proteins marked for destruction. Recently, a number of proteasome inhibitors have shown promise against cancer. One of these inhibitors, bortezomib (Velcade), has proven effective against a number of cancers, including myeloma and certain forms of lymphoma.

The new research, which appears in the online journal PLoS ONE, points to the possible anti-cancer use of thiazoles in the future. In a university news release, study author Andrei Gartel, an associate professor of molecular genetics, said that by using thiazole antibiotics in combination with well-known proteasome inhibitors, "we may see a synergy that allows us to markedly reduce the dose of any one of these drugs and still effectively kill the cancer cells."

More information

Read more about cancer treatments at the U.S. National Cancer Institute.

SOURCE: University of Illinois at Chicago, news release, Aug. 11, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com